[Skip to Navigation]
September 1968

Incidence of Lens Changes in Patients Treated With Echothiophate Iodide

Author Affiliations

From Massachusetts Eye and Ear Infirmary, Boston. Dr. Thoft is currently a Captain in the US Army Medical Corps, US Army Hospital, Ft. Polk, La.

Arch Ophthalmol. 1968;80(3):317-320. doi:10.1001/archopht.1968.00980050319004

Sixteen glaucomatous patients were observed for a period of 7 to 21 months while echothiophate (Phospholine) iodide was applied to one eye for control of ocular pressure and other types of treatment were used in the contralateral eye as needed. Six of the patients received 0.06% or 0.12% echothiophate iodide but showed no change in their lenses during this period. Ten of the patients received 0.25% echothiopate iodide, and five of these did develop significant change in the appearance of the lens in the treated eye. The lens changes which seemed to be related to the application of echothiophate iodide tended to be nuclear and posterior subcapsular rather than anterior. Fine anterior subcapsular vacuoles which others have ascribed to echothiophate iodide were observed to be common in untreated elderly patients. The existence of specific lens changes attributable to echothiophate iodide seems open to question.

Add or change institution